Interplay of vasodilator and vasoconstrictor substances in the femoral arterial bed: identification of the angiotensin cofactor.
D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001681:Biological Assay; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000032:analysis / Q000494:pharmacology*; D002854:Chromatography, Paper; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D005263:Femoral Artery / Q000502:physiology*; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D009638:Norepinephrine / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011863:Radioimmunoassay; D012039:Regional Blood Flow / Q000187:drug effects; D013667:Technetium; D014439:Tyramine / Q000494:pharmacology; D014665:Vasodilator Agents / Q000032:analysis / Q000494:pharmacology*
D011453:Prostaglandins; D014665:Vasodilator Agents; D000804:Angiotensin II; D013667:Technetium; D000255:Adenosine Triphosphate; D000109:Acetylcholine; D001920:Bradykinin; D009638:Norepinephrine; D014439:Tyramine